Department of Emergency Medicine

Sections



Prehospital and Disaster Medicine

The core mission of Emory's prehospital and disaster medicine section is patient-centric, and where patients are involved, physicians must demonstrate leadership to help ensure that patients receive the timely, competent and compassionate care they deserve. 

Global Health

Global Emergency Medicine (EM) is a subspecialty of Emory Emergency Medicine that deals with, the development of the specialty of EM internationally, provision of emergency care globally, disaster and humanitarian response, global health research

Observation Medicine

Observation medicine encompasses the management of selected patients for a timeframe of 6 to 24 hours to assess their need for inpatient admission. This service is best provided in a dedicated observation unit, ideally in the Emergency Department.

Toxicology

The Section of Medical Toxicology is devoted to teaching, patient care, and research in the field of Medical Toxicology. Since the establishment in 1996 with one toxicologist, the section has grown to include six Emergency Medicine trained medical toxicologists.

Ultrasound

The Emergency Medicine Section of Ultrasound is dedicated to educating our medical students, residents, and fellows, promoting research and scholarship of ultrasound, incorporating bedside ultrasound into clinical care using best practices

Research

The Innovation and Discovery in the Emergent and Acute Sciences (IDEAS) group in the Department of Emergency Medicine exists to support and grow research and researchers in the Department. The IDEAS group does this by removing barriers to research.

News

A new five-year, $3.1 million grant from the NIH will help Emory researchers undertake a novel study to better understand the symptoms of cystic fibrosis.

Emory University and Georgia Public Broadcasting (GPB) are excited to announce the premiere of Season 5 of the Emmy award-winning PBS television series, “Your Fantastic Mind,” scheduled to debut on April 17 at 7 p.m. ET.

Groundbreaking results from a six-year clinical trial investigating treatment for hemorrhagic strokes, led by researchers at Emory University School of Medicine, show the minimally invasive approach under study is safe and superior to the current standard of care, marking a major advancement in the treatment of intracerebral hemorrhage, the deadliest form of stroke.